Skolnick Phil 4
4 · OPIANT PHARMACEUTICALS, INC. · Filed Jan 31, 2023
Insider Transaction Report
Form 4
Skolnick Phil
Chief Scientific Officer
Transactions
- Sale
Common Stock
2023-01-27$20.26/sh−480$9,725→ 21,548 total
Footnotes (1)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.